Bariatric surgery leads to a reduction in antibodies to apolipoprotein A-1: a prospective cohort study
Ho, Jan H
Ammori, B. J.
Syed, A. A.
Durrington, P. N.
Malik, R. A.
AffiliationFaculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
MetadataShow full item record
CitationAdam S, Ho JH, Liu Y, Siahmansur T, Iqbal Z, Pagano S, et al. Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort Study Obesity Surgery. Springer Science and Business Media LLC; 2021.
- Effect of Bariatric Surgery on High-Density Lipoprotein (HDL) Cholesterol in Non-diabetic Patients with Severe Obesity.
- Authors: Nienov OH, Machado FD, Dias LS, De Carli LA, Schmid H
- Issue date: 2020 Jan
- Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
- Authors: Antiochos P, Marques-Vidal P, Virzi J, Pagano S, Satta N, Bastardot F, Hartley O, Montecucco F, Mach F, Waeber G, Vollenweider P, Vuilleumier N
- Issue date: 2016 Sep 27
- Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios.
- Authors: Diaf M, Khaled BM, Sellam F
- Issue date: 2015
- Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
- Authors: Alemzadeh R, Kichler J
- Issue date: 2018 Feb
- Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
- Authors: Kjellmo CA, Karlsson H, Nestvold TK, Ljunggren S, Cederbrant K, Marcusson-Ståhl M, Mathisen M, Lappegård KT, Hovland A
- Issue date: 2018 Jan-Feb